Owens & Minor Inc. Aktie
22,60 €
Deine Einschätzung
Owens & Minor Inc. Aktie
Was spricht für und gegen Owens & Minor Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Owens & Minor Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Owens & Minor Inc. | -1,74 % | 1,77 % | -2,54 % | 61,97 % | 31,43 % | -26,89 % | - |
Orasure Tech | -0,98 % | 4,51 % | -11,30 % | -18,40 % | -31,54 % | -36,93 % | -40,03 % |
scPharmaceuticals | -7,80 % | 9,00 % | -7,63 % | -51,56 % | -24,17 % | -20,73 % | - |
SI-BONE Inc | -2,14 % | -0,71 % | -0,71 % | -26,70 % | -26,32 % | -51,05 % | - |
Kommentare
News
Owens & Minor Announces First Quarter 2024 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange.
The Company will
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.
Full Year 2023 Key Highlights:
-
Consolidated revenue of $10.3 billion
Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.
The Company